CSL's Financial Results
CSL's annual profit and final dividend announcement for 2018/19 was announced on 14th August 2019. Please click to view our historic Full Year and Half Year Financial Results.More Information
Search Results147 results found
CSL Limited ABN: 99 051 588 348 ASX Full-year information 30 June 2019 Lodged with the ASX under Listing Rule 4.3A.
Results for Announcement to the Market 2019 2018 US$m US$m Sales revenue 8,205.4 7,587.9 Total other revenues 333.2 327.4 Total revenue and other income 8,538.6 7,915.3 Profit before income tax expense 2,341.1 2,281.2 Income tax expense (422.4) (552.3) Reported Net profit after tax attributable to members of the parent entity 1,918.7 1,728.9
24 CSL Financial Statements 30 June 2018 The results of the impairment test show that each business unit's recoverable Intangible assets with indefinite useful lives are not amortised.
We have announced our 2019 Half Year Results.
CSL Limited have announced 2018 Full Year Results for the period ending 30 June 2018. Full details available here.
The myelin sheath, or the protective covering of the nerves, is damaged, which In October 2018, an expanded age indication for AFLURIA® may result in numbness or tingling, muscle weakness, fatigue QUADRIVALENT (influenza vaccine) for use in people six and other symptoms which worsen over time.
CSL's exceptionally strong performance is a result of the focused execution of our strategy. Learn more.
AASB 16 - Leases There are no matters or circumstances which have arisen since 31 December This standard introduces a single lessee accounting model and requires a lessee 2018 which have significantly affected, or may significantly affect, the to recognise assets and liabilities for all leases with a term of more than 12 operations of the Group, the results of operations, or the state of affairs of months, unless the underlying asset is of low value.
For further details, please refer to the ASX announcement of Half Year results lodged on 14 February 2018.
For immediate release 15 August 2018 CSL Delivers a Full Year Net Profit of $1.7 billion1
pending test results after 2018), CSL Plasma donors related their Find out more at Find out more at a donation is made.*